ABVC BioPharma, Inc. (ABVC) Operating cash flow 2017–2025
ABVC BioPharma, Inc. (ABVC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.0MFY2025 · since FY2017: -$1.5M → -$3.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.0M | -65.1% |
| FY2024 | -$1.8M | +56.8% |
| FY2023 | -$4.2M | +43.4% |
| FY2022 | -$7.4M | +2.6% |
| FY2021 | -$7.6M | -66.5% |
| FY2020 | -$4.6M | -45.6% |
| FY2019 | -$3.1M | -248.1% |
| FY2018 | -$900,531 | +39.4% |
| FY2017 | -$1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABVC financial trends
ABVC RevenueABVC Net incomeABVC Net marginABVC Gross profitABVC Gross marginABVC Operating incomeABVC Operating marginABVC Free cash flowABVC Capital expendituresABVC Return on equityABVC Stock buybacksABVC Dividends paidABVC Total assetsABVC Total liabilitiesABVC Shareholders’ equityABVC overview →